A Double-Blind, Randomized, Multicenter Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures.
Phase of Trial: Phase III
Latest Information Update: 10 Jan 2014
At a glance
- Drugs Pregabalin (Primary)
- Indications Partial epilepsies
- Focus Registrational; Therapeutic Use
- Sponsors Pfizer
- 04 Dec 2012 Results presented at the 66th Annual Meeting of the American Epilepsy Society.
- 22 Feb 2012 Status of the extension trial is completed (EudraCT2009-016850-42).
- 25 Jan 2012 Actual patient number changed from 73 to 75 as reported by ClinicalTrials.gov (Extension trial: NCT00596466).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History